REGENXBIO Inc.
RGNX
$9.01
$0.9011.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.17% | 39.38% | 13.81% | 8.34% | 12.07% |
| Total Depreciation and Amortization | -6.46% | -7.69% | -6.38% | -3.41% | 3.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.61% | -29.91% | -16.62% | -7.05% | -13.85% |
| Change in Net Operating Assets | 1,259.92% | 184.84% | 150.82% | 123.28% | -33.17% |
| Cash from Operations | 54.02% | 56.44% | 20.73% | 16.02% | 12.36% |
| Capital Expenditure | 21.58% | 49.06% | 75.54% | 82.64% | 79.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.63% | -6.01% | -47.30% | -49.67% | -58.72% |
| Cash from Investing | -106.03% | -4.27% | -45.82% | -47.11% | -56.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.13% | -99.19% | 1,524.84% | 1,560.45% | 3,487.79% |
| Repurchase of Common Stock | 47.26% | 37.69% | -130.79% | -130.79% | -130.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 360.38% | 22.43% | 6.64% | -12.03% | -21.76% |
| Cash from Financing | 21.51% | -135.69% | 365.07% | 377.10% | 390.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 297.04% | -60.06% | 136.85% | 105.13% | 78.95% |